The Chromosome Dynamics Group
We are based in the Wellcome Trust Centre for Human Genetics, in the Nuffield Department of Medicine at the University of Oxford (and in the Department of Zoology at the University of Cambridge). We study the processes that occur at replications forks and in replication factories in mammalian cells. These are likely to be physical cellular locations where the genome instability arises that can lead to cancer and other disorders. Cells have to coordinate a large number of activities at each replication fork, and this seems to involve the key replication protein PCNA that acts as a sliding clamp to recruit enzymes and regulators of DNA replication to the right place at the right time. We are particularly interested in processes that ensure the maintenance of genetic and epigenetic stability during DNA replication, but we will be looking also at the origins of chromosomal alterations: copy number variations and translocations, and the relationship between these, replication timing and the three dimensional organisation of the nucleus.
Projects in the lab include:
- Determination of the full complement of PCNA interactors, and how this is modified upon replication stress (Simon Cooper – BBSRC funded). This project uses affinity purification and high throughput bimolecular fluorescence complementation (BiFC) screens to identify and characterise novel PCNA interactors.
- Dynamics of PCNA interactions at replication forks (Shiphali Shetty – CRUK funded). This project uses fluorescence resonance energy transfer (FRET) to monitor protein-protein interactions in real time in living cells.
- Structure-function of PCNA in replication and repair (Helen Chambers – CRUK funded). This project is investigating how different mutations of PCNA affect its role in diverse cellular processes.
- PCNA involvement in epigenetic inheritance (Diana Vallejo – funded by the Generalitat Valenciana). This project uses a combination of protein biochemistry and Drosophila genetics to investigate the role of PCNA in coordinating the transmission of epigenetic states during DNA replication.
- Substrate identification for protein methyltransferases (Lucie Maingot - funded by the Cambridge Cancer Centre (in collaboration with Chris Abell)). This project involves the design and synthesis of S-adenosyl methionine derivatives to label methylated proteins in vitro and in vivo.
- Physical structure of replication foci and its relationship with genome stability (Michal Gdula – funded by the Wellcome Trust). This project is investigating how the three-dimensional organisation of the nucleus affects the replication program and the formation of chromosome translocations.
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Ewer KJ. et al, (2021), Nature Medicine, 27, 270 - 278
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
Genomic Instability Is an Early Event in Aluminium-Induced Tumorigenesis.
Mandriota SJ. et al, (2020), International journal of molecular sciences, 21
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993